We are dedicated to improving the cure rates of women with gynecologic cancer through innovative clinical research. Gynecologic cancer is any cancer that is part of a woman’s reproductive organs and includes:
- Fallopian Tube
Ovarian Cancer Vaccine Update
We had an excellent meeting with Dr. Robert Dillman and CSR biotech personnel recently. The first phase of this project should launch soon. This first phase will involve collecting ovarian cancer specimen from six patients, and making individual vaccines for each patient. We need to do this to prove that the vaccine production process is perfected. We will then be able to move on to the actual vaccine trial, involving approximately ninety six patients. Hopefully the trial will start in January/February of 2015. If you would like to make a donation to support this “first in the world” trial, this can be done either in person at our office located at 351 Hospital Road Suite 506 Newport Beach, CA., 92663 or online at
Metformin Ovarian Cancer Trial
NYWCRF is actively working with the University of North Carolina (UNC) and Gynecologic Oncology Associates of Newport Beach to design a first line trial adding metformin to gold standard taxol/carboplatin chemotherapy treatment. Several retrospective trials have shown that metformin may be useful in treating cancer and possibly preventing cancer from developing. UNC has extensive animal data suggesting that this new combination might improve ovarian cancer cure rates. This will be a first in the world trial in humans. We expect the treatment to be well tolerated. Since metformin is off patent, no pharmaceutical company will fund the trial. NYWCRF will therefore fund this important trial itself. If you would like to help support this trial you can make a tax deductible donation on our website at,
Hike For the Cure – November 8th, 2014
Hike for The Cure
Video About The Hike: Video About the Hike
FaceBook Event Page: FaceBook Event Page
In Memory of
Jacqualine was 26 years old when she was diagnosed with stage IIB Cervical cancer. Of course the initial shock of the word cancer brought her to her knees in tears, but she picked herself up and stood strong in her faith. She gathered courage and marched forward in her fight, never having a pity party, whoa is me, or complaint. Through all the surgeries, the chemo, the radiation, she fought the fight as hard as she could. She eventually lost the battle, but the fight continues as we join The Nancy Yeary Women’s Cancer Research Foundation. Will you help us by donating in Jacqualine’s memory as we continue to search for the cure?
For wire transfers, please contact Janet Rae at 949-642-5165 or Janet.Rae@gynoncology.com
Appointed to the Board of Directors
Vivian Panou is the director of special events and projects at Earth Friendly Products: the manufacturer of ECOS, the world’s top selling green laundry detergent. In her post, Vivian communicates Earth Friendly’s sustainability mission and products with the press, school children, parent groups and professional organizations through live presentations and events. Vivian also organizes relationships between the company and non-profit organizations which strive to improve people’s health and that of the environment like Grades of Green, Sustainable Business Council, the National Women’s History Museum, Cystic Fibrosis Association, Autism Hope Alliance, and the Nancy Yeary Women’s Cancer Research Foundation of which she proudly serves on the board of directors. Prior to joining Earth Friendly Products, Vivian was a television reporter in Chicago and Greece and today puts “ink to paper” as an online writer for EXAMINER.com. Vivian is fueled to spread the news of leading a sustainable business and life by her two daughters, Katerina, age 10 and Aria, Age 8.
The Nancy Yeary Women’s Cancer Research Foundation is a proud sponsor of Globeathon.
The Global Video: The Global Video
The Universal Video: The Universal Video